US Patent Issued to National Jewish Health on Sept. 9 for "Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders" (Colorado Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,477, issued on Sept. 9, was assigned to National Jewish Health (Denver).

"Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders" was invented by David A. Schwartz (Aurora, Colo.) and Max Seibold (Denver).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides diagnostic and therapeutic targets for pulmonary disease, in particular, fibrotic lung disease. The inventors have found that a genetic variant MUC5B gene is associated with increased expression of the gene, increased risk of developing a pulmonary disease, and an improved prognosis and survival among those developing the pulmonar...